Get started
Author

Maria de los Llanos GIL Gil Moreno

Using genetics to predict patient response to platinum-based chemotherapy
2017 · Niki Karachaliou, Maria de los Llanos Gil Moreno, et al. · Expert Review of Precision Medicine and Drug Development · 9
A Single-Center Retrospective Study of Patients with Double Primary Cancers: Breast Cancer and EGFR-Mutant Non-Small Cell Lung Cancer
2019 · Teresa Moran, Vanesa Quiroga, et al. · Oncology Research and Treatment · 7
Prevalence of ROS1 translocation, HER2, and BRAF mutations in a cohort of advanced Non-Small Cell Lung Cancer (NSCLC) patients (p) triple negative (TN).
2015 · Enric Carcereny Costa, Anna Estival, et al. · Journal of Clinical Oncology · 2
Effect of central nervous system (CNS) metastases in a real-world multicenter cohort study of Spanish ALK-positive non-small cell lung cancer (NSCLC) patients (p)
2019 · L. Angelats, M.R. Garcia Campelo, et al. · Annals of Oncology
Society Bulletins
2019 · Teresa Moran, Vanesa Quiroga, et al. · Oncology Research and Treatment
PDF
Impact of three and further treatment lines in advanced non-small cell lung cancer patients according to molecular profile: A retrospective analysis.
2015 · Maria de los Llanos GIL Gil Moreno, Teresa Moran, et al. · Journal of Clinical Oncology
Non-Small Cell Lung Cancer (NSCLC) harboring Epidermal Growth Factor Receptor mutations (EGFR-m) and breast cancer (BC): A retrospective analysis of a single institution.
2015 · Teresa Moran, Vanesa Quiroga, et al. · Journal of Clinical Oncology
Works count: 8
Citation count: 18
H-index: 2
I10-index:
Year
Topic
Type